IRTC vs. GKOS, IART, NARI, AXNX, ATRC, NUVA, HAE, ATEC, ICUI, and TMCI
Should you be buying iRhythm Technologies stock or one of its competitors? The main competitors of iRhythm Technologies include Glaukos (GKOS), Integra LifeSciences (IART), Inari Medical (NARI), Axonics (AXNX), AtriCure (ATRC), NuVasive (NUVA), Haemonetics (HAE), Alphatec (ATEC), ICU Medical (ICUI), and Treace Medical Concepts (TMCI). These companies are all part of the "surgical & medical instruments" industry.
iRhythm Technologies vs.
Glaukos (NYSE:GKOS) and iRhythm Technologies (NASDAQ:IRTC) are both mid-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, media sentiment, valuation, profitability, analyst recommendations, community ranking, institutional ownership, risk and dividends.
iRhythm Technologies has a net margin of -24.34% compared to Glaukos' net margin of -48.15%. Glaukos' return on equity of -21.20% beat iRhythm Technologies' return on equity.
Glaukos currently has a consensus price target of $61.67, indicating a potential downside of 9.66%. iRhythm Technologies has a consensus price target of $151.40, indicating a potential upside of 48.69%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, analysts plainly believe iRhythm Technologies is more favorable than Glaukos.
Glaukos has a beta of 1.23, suggesting that its share price is 23% more volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.4, suggesting that its share price is 40% more volatile than the S&P 500.
92.2% of Glaukos shares are held by institutional investors. Comparatively, 99.0% of iRhythm Technologies shares are held by institutional investors. 7.8% of Glaukos shares are held by insiders. Comparatively, 0.4% of iRhythm Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Glaukos received 28 more outperform votes than iRhythm Technologies when rated by MarketBeat users. Likewise, 66.34% of users gave Glaukos an outperform vote while only 66.08% of users gave iRhythm Technologies an outperform vote.
In the previous week, Glaukos had 8 more articles in the media than iRhythm Technologies. MarketBeat recorded 24 mentions for Glaukos and 16 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 0.58 beat Glaukos' score of 0.20 indicating that iRhythm Technologies is being referred to more favorably in the news media.
Glaukos has higher earnings, but lower revenue than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Glaukos, indicating that it is currently the more affordable of the two stocks.
Summary
Glaukos beats iRhythm Technologies on 10 of the 18 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding IRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
iRhythm Technologies Competitors List
Related Companies and Tools
